847 related articles for article (PubMed ID: 25609158)
1. Early B-cell factor 3 (EBF3) is a novel tumor suppressor gene with promoter hypermethylation in pediatric acute myeloid leukemia.
Tao YF; Xu LX; Lu J; Hu SY; Fang F; Cao L; Xiao PF; Du XJ; Sun LC; Li ZH; Wang NN; Su GH; Li YH; Li G; Zhao H; Li YP; Xu YY; Zhou HT; Wu Y; Jin MF; Liu L; Zhu XM; Ni J; Wang J; Xing F; Zhao WL; Pan J
J Exp Clin Cancer Res; 2015 Jan; 34(1):4. PubMed ID: 25609158
[TBL] [Abstract][Full Text] [Related]
2. Hypermethylation of the GATA binding protein 4 (GATA4) promoter in Chinese pediatric acute myeloid leukemia.
Tao YF; Fang F; Hu SY; Lu J; Cao L; Zhao WL; Xiao PF; Li ZH; Wang NN; Xu LX; Du XJ; Sun LC; Li YH; Li YP; Xu YY; Ni J; Wang J; Feng X; Pan J
BMC Cancer; 2015 Oct; 15():756. PubMed ID: 26490736
[TBL] [Abstract][Full Text] [Related]
3. Metallothionein III (MT3) is a putative tumor suppressor gene that is frequently inactivated in pediatric acute myeloid leukemia by promoter hypermethylation.
Tao YF; Xu LX; Lu J; Cao L; Li ZH; Hu SY; Wang NN; Du XJ; Sun LC; Zhao WL; Xiao PF; Fang F; Li YH; Li G; Zhao H; Li YP; Xu YY; Ni J; Wang J; Feng X; Pan J
J Transl Med; 2014 Jun; 12():182. PubMed ID: 24962166
[TBL] [Abstract][Full Text] [Related]
4. tp53-dependent G2 arrest mediator candidate gene, Reprimo, is down-regulated by promoter hypermethylation in pediatric acute myeloid leukemia.
Tao YF; Li ZH; Wang NN; Fang F; Xu LX; Pan J
Leuk Lymphoma; 2015; 56(10):2931-44. PubMed ID: 25629980
[TBL] [Abstract][Full Text] [Related]
5. Zinc finger protein 382 is downregulated by promoter hypermethylation in pediatric acute myeloid leukemia patients.
Tao YF; Hu SY; Lu J; Cao L; Zhao WL; Xiao PF; Xu LX; Li ZH; Wang NN; Du XJ; Sun LC; Zhao H; Fang F; Su GH; Li YH; Li YP; Xu YY; Ni J; Wang J; Feng X; Pan J
Int J Mol Med; 2014 Dec; 34(6):1505-15. PubMed ID: 25319049
[TBL] [Abstract][Full Text] [Related]
6. The promoter of miR-663 is hypermethylated in Chinese pediatric acute myeloid leukemia (AML).
Yan-Fang T; Jian N; Jun L; Na W; Pei-Fang X; Wen-Li Z; Dong W; Li P; Jian W; Xing F; Jian P
BMC Med Genet; 2013 Jul; 14():74. PubMed ID: 23870168
[TBL] [Abstract][Full Text] [Related]
7. MN1 overexpression is driven by loss of DNMT3B methylation activity in inv(16) pediatric AML.
Larmonie NSD; Arentsen-Peters TCJM; Obulkasim A; Valerio D; Sonneveld E; Danen-van Oorschot AA; de Haas V; Reinhardt D; Zimmermann M; Trka J; Baruchel A; Pieters R; van den Heuvel-Eibrink MM; Zwaan CM; Fornerod M
Oncogene; 2018 Jan; 37(1):107-115. PubMed ID: 28892045
[TBL] [Abstract][Full Text] [Related]
8. DOK6 promoter methylation serves as a potential biomarker affecting prognosis in de novo acute myeloid leukemia.
Sun GK; Tang LJ; Zhou JD; Xu ZJ; Yang L; Yuan Q; Ma JC; Liu XH; Lin J; Qian J; Yao DM
Cancer Med; 2019 Oct; 8(14):6393-6402. PubMed ID: 31486300
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic landscape of the TERT promoter: a potential biomarker for high risk AML/MDS.
Zhao X; Tian X; Kajigaya S; Cantilena CR; Strickland S; Savani BN; Mohan S; Feng X; Keyvanfar K; Dunavin N; Townsley DM; Dumitriu B; Battiwalla M; Rezvani K; Young NS; Barrett AJ; Ito S
Br J Haematol; 2016 Nov; 175(3):427-439. PubMed ID: 27433923
[TBL] [Abstract][Full Text] [Related]
10. Identification of differentially methylated markers among cytogenetic risk groups of acute myeloid leukemia.
Qu X; Davison J; Du L; Storer B; Stirewalt DL; Heimfeld S; Estey E; Appelbaum FR; Fang M
Epigenetics; 2015; 10(6):526-35. PubMed ID: 25996682
[TBL] [Abstract][Full Text] [Related]
11. Protein tyrosine phosphatases receptor type D is a potential tumour suppressor gene inactivated by deoxyribonucleic acid methylation in paediatric acute myeloid leukaemia.
Song L; Jiang W; Liu W; Ji JH; Shi TF; Zhang J; Xia CQ
Acta Paediatr; 2016 Mar; 105(3):e132-41. PubMed ID: 26607758
[TBL] [Abstract][Full Text] [Related]
12. Genome-wide methylation sequencing of paired primary and metastatic cell lines identifies common DNA methylation changes and a role for EBF3 as a candidate epigenetic driver of melanoma metastasis.
Chatterjee A; Stockwell PA; Ahn A; Rodger EJ; Leichter AL; Eccles MR
Oncotarget; 2017 Jan; 8(4):6085-6101. PubMed ID: 28030832
[TBL] [Abstract][Full Text] [Related]
13. Promoter of TFPI-2 is hypermethylated in Chinese pediatric acute myeloid leukemia.
Jian P; Yan WS; Chao SL; Liang P; Zhen L; Ling QB; Hong LY; Ping LY; Jian W; Fang JM; Ling L; Dong WX; Ming ZX; Jian N
J Pediatr Hematol Oncol; 2012 Jan; 34(1):43-6. PubMed ID: 22052167
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-183 promotes cell proliferation via regulating programmed cell death 6 in pediatric acute myeloid leukemia.
Wang X; Zuo D; Yuan Y; Yang X; Hong Z; Zhang R
J Cancer Res Clin Oncol; 2017 Jan; 143(1):169-180. PubMed ID: 27738758
[TBL] [Abstract][Full Text] [Related]
15. An EBF3-mediated transcriptional program that induces cell cycle arrest and apoptosis.
Zhao LY; Niu Y; Santiago A; Liu J; Albert SH; Robertson KD; Liao D
Cancer Res; 2006 Oct; 66(19):9445-52. PubMed ID: 17018599
[TBL] [Abstract][Full Text] [Related]
16. Decreased SCIN expression, associated with promoter methylation, is a valuable predictor for prognosis in acute myeloid leukemia.
Zhang ZH; Zhang W; Zhou JD; Zhang TJ; Ma JC; Xu ZJ; Lian XY; Wu DH; Wen XM; Deng ZQ; Lin J; Qian J
Mol Carcinog; 2018 Jun; 57(6):735-744. PubMed ID: 29457658
[TBL] [Abstract][Full Text] [Related]
17. Methylation-independent CHFR expression is a potential biomarker affecting prognosis in acute myeloid leukemia.
Zhou JD; Zhang TJ; Li XX; Ma JC; Guo H; Wen XM; Yao DM; Zhang W; Lin J; Qian J
J Cell Physiol; 2018 Jun; 233(6):4707-4714. PubMed ID: 29115660
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA 34b inhibits cell proliferation in pediatric acute myeloid leukemia via regulating LDHA.
Qi HX; Cao Q; Zhou GP; Sun XZ; Zhou WD; Hong Z; Hu J; Juan CX; Li S; Kuai WX
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5351-5359. PubMed ID: 31298387
[TBL] [Abstract][Full Text] [Related]
19. A critical role of epigenetic inactivation of miR-9 in EVI1
Mittal N; Li L; Sheng Y; Hu C; Li F; Zhu T; Qiao X; Qian Z
Mol Cancer; 2019 Feb; 18(1):30. PubMed ID: 30813931
[TBL] [Abstract][Full Text] [Related]
20. Promoter methylation of DAPK1, E-cadherin and thrombospondin-1 in de novo and therapy-related myeloid neoplasms.
Greco M; D'Alò F; Scardocci A; Criscuolo M; Fabiani E; Guidi F; Di Ruscio A; Migliara G; Pagano L; Fianchi L; Chiusolo P; Hohaus S; Leone G; Voso MT
Blood Cells Mol Dis; 2010 Oct; 45(3):181-5. PubMed ID: 20655775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
